Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Bullboard (TSXV:TLT)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Comment by enriquesuaveon Sep 05, 2024 1:00pm

RE:RE:RE:General question for the board

I beg to differ!  CGON has BTD for the same indication and has a MC of $2.5  Billion USD!  They have 300 million in cash, but don't have virus inactivation, they don't have ...more  
180
Discussion
Comment by Bigkahuna57on Sep 05, 2024 12:52pm

RE:RE:General question for the board

I'd guess the BTD approval, while signifcant as a necessary step in the progress toward FDA approval doesn't move the SP much.  It's critically important b/c it leads to AA. And I' ...more  
139
Discussion
Comment by reconsideron Sep 05, 2024 10:29am

RE:General question for the board

I say that'd depend on the money in the coffers. If we have none, the price spike may be shy because we all know that dilution will follow (in more favoreable conditions). If we have some, I'd ...more  
158
Discussion
Comment by Lesalpes29on Sep 05, 2024 7:40am

RE:RE:RE:General question for the board

PP NR will probably be the next one. Hope to see a couple of millions in the coffer. It could be the first SP ajustement. Pre-BTD NR will probably put it over .40. I stay prudent! GL
124
Discussion
Comment by Feedman2980on Sep 05, 2024 7:27am

RE:RE:General question for the board

That would certainly be nice. 50 cents would be a good starting point
84
Discussion
Comment by TimboBagginson Sep 05, 2024 12:40am

RE:RE:RE:General question for the board

lol. I sold a lot of TSLA and NVDA in 2017 to buy more TLT.  wish I held onto those guys for a bit longer. 
98
Discussion
Comment by Infinityon Sep 04, 2024 9:58pm

RE:RE:General question for the board

I do wish that I had bought TLT yesterday instead of 10+ years ago!!
89
Discussion
Comment by Johnandrose22on Sep 04, 2024 7:37pm

RE:RE:RE:RE:RE:RE:New Proactive Video

Oh, Cancerslayer...your data driven image is, indeed, powerful....Perhaps our small, seemingly insignificant company will be the Say Hey Kid of healthcare....I saw Willie Mays play...a relatively ...more  
187
Discussion
Comment by StevenBirchon Sep 04, 2024 7:33pm

RE:RE:RE:RE:RE:RE:New Proactive Video

I thought you were quite clear CS.
81
Discussion
Comment by CancerSlayeron Sep 04, 2024 7:12pm

RE:RE:RE:RE:RE:New Proactive Video

Chicken pox is also a member of the Herpes Virus family & hence shares similar characteristics (i.e. enveloped, double-stranded DNA virus)...just presents with different clinical manifestations. & ...more  
157
Discussion
Comment by Longholder99on Sep 04, 2024 6:23pm

RE:RE:RE:RE:New Proactive Video

I wonder if this could stop a chicken pox infections.  
86
Discussion
Comment by CancerSlayeron Sep 04, 2024 6:21pm

RE:RE:RE:RE:RE:New Proactive Video

Early innings of "HSV-1 research"...sorry for the unsettling confusion.
96
Discussion
Post by Dumbeldorfwhiteon Sep 04, 2024 5:46pm

All these Peter dish experiments remind me of

All the preclinical tld 1633 experiments,you know the one that's 15% more effective than their current drug. Yet we never heard of it again. It's like it's a distraction to the fact that ...more  
280
Comment by menoalittleon Sep 04, 2024 4:58pm

RE:General question for the board

>> In short, what share price might BTD bring? Immediately or eventually?  (Because I expect there to be a vast difference...
112
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube



INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250